The Features of COVID-19’s Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria

The Features of COVID-19’s Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria

COVID-19 and other infectious diseases can exacerbate the course of paroxysmal nocturnal hemoglobinuria (PNH). The efficacy and safety of the Gam-COVID-Vac vaccine in patients with PNH has not been adequately studied. A retrospective, observational, cohort, non-comparative study was performed to ass...

Full description

Bibliographic Details
Main Authors: Vadim Ptushkin, Evgeniya Arshanskaya, Olga Vinogradova, Dmitry Kudlay, Eugene Nikitin
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Hematology Reports
Subjects:
paroxysmal nocturnal hemoglobinuria
COVID-19
Gam-COVID-Vac
SARS-CoV-2
anti-SARS-CoV-2 IgG
eculizumab
Online Access:https://www.mdpi.com/2038-8330/15/3/52

Similar Items

Similar Items